Report : Fish Vaccine Market Size, Share, Growth by 2030
According to our latest study on " Fish Vaccine Market Size and Forecast to 2030 – COVID-19 Impact and Global Analysis – by Vaccine Type, Route of Administration, Species, and Application," the fish vaccine market size was valued at US$ 355.88 million in 2022 and is expected to reach US$ 617.38 million by 2030. It is estimated to register a CAGR of 7.1% during 2022–2030. The report highlights the key factors and trends impacting the market and focuses on prominent players and their strategies.
Fish can be immunized by immersion in vaccine for a short period of time. They can be immunized by injection, intramuscularly or intraperitoneally, and orally by mixing vaccines with feed either by top dressing or by incorporating into feed as an ingredient. Fish also respond to vaccine the same way as other animals do, but since fish are cold-blooded animals, the response to vaccine depends largely on the water temperature.
An unhealthy diet is a growing concern in developing and developed countries, resulting in a variety of negative health consequences. Thus, fish is highly advisable in diet for healthy growth and development as it is rich in vitamins, minerals, lipids, and macronutrients such as proteins. Additionally, it is believed that aquaculture is the most effective way to produce high-quality proteins for a sustainable human diet.
Worldwide Fish Production and Consumption in 2022
| Category | Region | Production (Metric Ton) | Consumption (Metric Ton) |
| FISH | World | 183,046,000 | 182,421,000 |
| Developed countries | 28,864,000 | 36,509,000 | |
| Developing countries | 154,182,000 | 145,987,000 | |
| FISHMEAL | World | 4,974,200 | 5,001,800 |
| Developed countries | 1,471,900 | 1,516,200 | |
| Developing countries | 3,501,200 | 3,785,600 | |
| FISH OIL | World | 1,169,100 | 1,181,900 |
| Developed countries | 435,800 | 650,300 | |
| Developing countries | 733,300 | 481,600 |
Source: OECD/FAO
Growing awareness regarding the nutritional benefits of fish consumption propels the demand for sustainable, high-quality, and healthy meat products. Therefore, the rising consumption of fish and fish-derived products fuels the fish vaccines market growth.
Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.
Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India.
Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth.
Cole Instruments Inc, Vision Medical Inc, Bernstein Medical PC, Curallux LLC, HairMax Inc, NovaGenix LLC, Apira Science Inc, Theradome Inc, Robotics Restoration Inc, and LaserCap Co are among the key players operating in the global fish vaccine market.
The report segments the global fish vaccine market as follows:
The fish vaccine market is divided on the basis of vaccine type, application, route of administration, and species. Based on vaccine type, the fish vaccine market is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccine, and others. Based on the application, the fish vaccine market is segmented into bacterial, viral, and parasitic. Based on the route of administration, the fish vaccine market is classified into injected, immersion, and oral. Based on species, the fish vaccine market is segmented into salmon, trout, tilapia, and others. Based on geography, the fish vaccine market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com